RCM News and Press, R1 RCM Inc. From 04/21/22

MURRAY, Utah, April 21, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it expects to release financial results for the three months...

MURRAY, Utah, April 07, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that Project Roadrunner Parent Inc., a wholly owned subsidiar...

Potential of telemedicine, big data, artificial intelligence, and administrative digitization in the healthcare sector is huge. EDOC has done quite an effective reshuffling of its portfolio. EDOC is on a downward trend, but has strong potential in the long run. For further d...

The following slide deck was published by R1 RCM Inc. in conjunction with this event. For further details see: R1 RCM (RCM) Presents At 42nd Annual Cowen Health Care Conference

MURRAY, Utah, March 01, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today released its 2021 Environmental, Social, and Governance (ESG) repor...

R1 RCM, Inc. (RCM) Q4 2021 Earnings Conference Call February 17, 2022, 8:00 am ET Company Participants Atif Rahim - Head, IR Joe Flanagan - President & CEO Rachel Wilson - EVP & CFO Conference Call Participants James Auh - Cowen Vikram Kesavabhotla - Baird Sean Dodge - RBC Capital Mar...

Gainers: Aridis Pharmaceuticals ARDS +12%. Rhythm Pharmaceuticals RYTM +12%. Outset Medical (NASDAQ:OM) +10%. Masimo (NASDAQ:MASI) +8%. Vivos Therapeutics (NASDAQ:VVOS) +7%. Losers: 10x Genomics (NASDAQ:TXG) -16%. iSpecimen ISPC -10%. Poseida ...

R1 RCM press release (NASDAQ:RCM): Q4 GAAP EPS of $0.11 beats by $0.01. Revenue of $398.9M (+21.5% Y/Y) in-line. For further details see: R1 RCM GAAP EPS of $0.11 beats by $0.01, revenue of $398.9M in-line

MURRAY, Utah, Feb. 17, 2022 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced results for the three months and year ended December 31, 2021...

R1 RCM (NASDAQ:RCM) is scheduled to announce Q4 earnings results on Thursday, February 17th, before market open. The consensus EPS Estimate is $0.14 (-44.0% Y/Y) and the consensus Revenue Estimate is $399.26M (+21.6% Y/Y). Over the last 3 months, EPS estimates have seen 1 upward revision and ...